European TORS Guidelines for Head and Neck Cancer
A landmark consensus establishing standardized indications, contraindications, and perioperative care for transoral robotic surgery
Welcome back to the Head & Neck Oncology Journal Club! This week we're examining a significant new European consensus paper that provides the first comprehensive surgical practice guidelines for transoral robotic surgery (TORS) in head and neck cancer management.
The Paper at a Glance
European surgical guidelines: transoral robotic surgery for head and neck cancers
Lechien JR, Paleri V, et al.
Oral Oncology 173 (2026) 107826
Why This Paper Matters
Despite TORS becoming increasingly prevalent over the past two decades, substantial heterogeneity has existed across centers regarding indications, surgical techniques, and perioperative care. This European consensus—endorsed by the EHNS, ELS, and YO-IFOS—aims to standardize practice and improve collaborative research.
Study at a Glance: 22 experts from 11 countries, modified Delphi process, 38/41 statements reached consensus.
Key Takeaways
TORS Indications by Site
Oropharyngeal Cancer:
cT1-T2 and selected cT3 cancers
HPV+ tumors particularly appropriate for de-escalation
3mm margins now validated as adequate for HPV+ disease
Supraglottic Laryngeal Cancer:
cT1-T2 (epiglottis, aryepiglottic fold, false cords)
Selected cT3 if ≥1cm margin from hyoid achievable
Hypopharyngeal Cancer:
cT1-T2 above horizontal cricoid plane only
All cT3-T4 are contraindicated
Critical Contraindications
Carotid artery invasion
50% tongue musculature resection required
Bilateral lingual artery ligation
cT4 disease at any site
Postoperative Care
Tracheostomy and feeding tube NOT mandatory for all cases
Hemorrhage: secure airway BEFORE controlling bleeding
IV steroids may reduce edema and pain
Speech therapy recommended for supraglottic cases
Bottom Line
This consensus provides surgeons with evidence-based guidance for TORS patient selection. The validation of 3mm margins for HPV+ disease and confirmation that TORS can avoid tracheostomy and prolonged feeding tube dependence reinforces its role as a less morbid alternative to open surgery.
🎧 Listen to Episode 006 for a 5-minute audio summary.
Until next time,
Krishnakumar Thankappan
The HN Oncology Journal Club Team